These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8584749)

  • 21. Drug delivery of antisense molecules to the brain for treatment of Alzheimer's disease and cerebral AIDS.
    Boado RJ; Tsukamoto H; Pardridge WM
    J Pharm Sci; 1998 Nov; 87(11):1308-15. PubMed ID: 9811482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy.
    Bergan R; Connell Y; Fahmy B; Neckers L
    Nucleic Acids Res; 1993 Jul; 21(15):3567-73. PubMed ID: 8346033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrastriatal and intraventricular injections of oligodeoxynucleotides in the rat brain: tissue penetration, intracellular distribution and c-fos antisense effects.
    Grzanna R; Dubin JR; Dent GW; Ji Z; Zhang W; Ho SP; Hartig PR
    Brain Res Mol Brain Res; 1998 Dec; 63(1):35-52. PubMed ID: 9838035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth.
    Williams SA; Chang L; Buzby JS; Suen Y; Cairo MS
    Leukemia; 1996 Dec; 10(12):1980-9. PubMed ID: 8946941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotides.
    Skorski T; Nieborowska-Skorska M; Wlodarski P; Perrotti D; Hoser G; Kawiak J; Majewski M; Christensen L; Iozzo RV; Calabretta B
    J Natl Cancer Inst; 1997 Jan; 89(2):124-33. PubMed ID: 8998181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The spread and uptake pattern of intracerebrally administered oligonucleotides in nerve and glial cell populations of the rat brain.
    Sommer W; Cui X; Erdmann B; Wiklund L; Bricca G; Heilig M; Fuxe K
    Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):75-85. PubMed ID: 9593045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spinal distribution and metabolism of 2'-O-(2-methoxyethyl)-modified oligonucleotides after intrathecal administration in rats.
    Butler M; Hayes CS; Chappell A; Murray SF; Yaksh TL; Hua XY
    Neuroscience; 2005; 131(3):705-15. PubMed ID: 15730875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
    Normand N; Valamanesh F; Savoldelli M; Mascarelli F; BenEzra D; Courtois Y; Behar-Cohen F
    Mol Vis; 2005 Mar; 11():184-91. PubMed ID: 15761390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.
    Broaddus WC; Chen ZJ; Prabhu SS; Loudon WG; Gillies GT; Phillips LL; Fillmore H
    Neurosurgery; 1997 Oct; 41(4):908-15. PubMed ID: 9316053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorescence microscopic comparison of the binding of phosphodiester and phosphorothioate (antisense) oligodeoxyribonucleotides to subcellular structures, including intermediate filaments, the endoplasmic reticulum, and the nuclear interior.
    Shoeman RL; Hartig R; Huang Y; Grüb S; Traub P
    Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):291-308. PubMed ID: 9303181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.
    Yoo BH; Bochkareva E; Bochkarev A; Mou TC; Gray DM
    Nucleic Acids Res; 2004; 32(6):2008-16. PubMed ID: 15064360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antisense oligodeoxynucleotides to bax mRNA promote survival of rat sympathetic neurons in culture.
    Gillardon F; Zimmermann M; Uhlmann E; Krajewski S; Reed JC; Klimaschewski L
    J Neurosci Res; 1996 Mar; 43(6):726-34. PubMed ID: 8984202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides.
    Perez JR; Li Y; Stein CA; Majumder S; van Oorschot A; Narayanan R
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5957-61. PubMed ID: 8016096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antisense oligodeoxynucleotides to inducible NO synthase rescue epithelial cells from oxidative stress injury.
    Peresleni T; Noiri E; Bahou WF; Goligorsky MS
    Am J Physiol; 1996 Jun; 270(6 Pt 2):F971-7. PubMed ID: 8764316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of hepadnaviral replication by polyethylenimine-based intravenous delivery of antisense phosphodiester oligodeoxynucleotides to the liver.
    Robaczewska M; Guerret S; Remy JS; Chemin I; Offensperger WB; Chevallier M; Behr JP; Podhajska AJ; Blum HE; Trepo C; Cova L
    Gene Ther; 2001 Jun; 8(11):874-81. PubMed ID: 11423935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorothioate oligodeoxynucleotides can selectively alter neuronal activity in the cochlea.
    LeBlanc CS; Fallon M; Parker MS; Skellett R; Bobbin RP
    Hear Res; 1999 Sep; 135(1-2):105-12. PubMed ID: 10491959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Optimal effects of liposome on antisense oligodeoxynucleotides uptake by mouse breast cancer TM40D cells and the effects of antisense oligodeoxynucleotides targeting c-erbB-2 on cell proliferation and apoptosis].
    Liu XA; Fan P; Wu ZY
    Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(13):802-5. PubMed ID: 15363300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of p21 antisense oligodeoxynucleotides on the radiosensitivity of nasopharyngeal carcinoma cells with normal p53 function.
    Liu XF; Xia YF; Li MZ; Wang HM; He YX; Zheng ML; Yang HL; Huang WL
    Cell Biol Int; 2006 Mar; 30(3):283-7. PubMed ID: 16448826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
    Cucco C; Calabretta B
    Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatobiliary elimination of bile acid-modified oligodeoxynucleotides in Wistar and TR- rats: evidence for mrp2 as carrier for oligodeoxynucleotides.
    Lischka K; Starke D; Failing K; Herling A; Kramer W; Petzinger E
    Biochem Pharmacol; 2003 Aug; 66(4):565-77. PubMed ID: 12906921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.